Northwest Biotherapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$0.39M $0.12M $0.08M $0.01M $0.01M $0.01M $0.01M $0.01M $0.77M $0.81M $1.45M $1.74M $0.62M $0.34M $0.41M $2.41M $1.29M $1.01M $1.68M $1.93M $0.00M
GM % Gross Margin %
89.74% 90.32% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$-4.23 $-5.72 $-2.00 $-2.29 $-1.68 $-0.85 $-0.85 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0.08m 0.08m 0.27m 2.65m 2.66m 3.63m 4.5m 9.33m 25.51m 44.14m 62.22m 95.86m 156.3m 324.86m 523.23m 601.33m 822.72m 947.62m 968.28m 0m 1188.73m
OCF Operating Cash Flow
$-4.43M $-4.18M $-6.93M $-14.60M $-15.59M $-4.68M $-6.38M $-14.71M $-22.75M $-37.80M $-54.58M $-79.71M $-55.65M $-36.50M $-34.59M $-31.86M $-32.09M $-38.30M $-52.78M $-53.64M $0.00M
FCF Free Cash Flow
$0.00M $-4.22M $0.00M $-14.62M $-15.99M $0.00M $-6.42M $-14.76M $-22.78M $0.00M $-88.31M $-86.46M $-60.59M $-36.51M $-34.78M $-32.22M $-38.70M $-44.32M $-55.68M $-57.08M $0.00M
FCFS Free Cash Flow Per Share
$-55.81 $-53.21 $-31.13 $-10.40 $-6.03 $-1.56 $-1.53 $-2.51 $-1.94 $-1.15 $-1.49 $-1.11 $-0.55 $-0.15 $-0.08 $-0.06 $-0.05 $-0.05 $-0.05 $-0.05 $0.00